Manasa Life Sciences is a leading manufacturer and supplier of nitrosamine impurities, providing high-quality reference standards for the global pharmaceutical industry. The company specializes in the custom synthesis and commercial supply of nitrosamine impurity standards required for pharmaceutical analysis, drug development, and quality control. With advanced R&D facilities and experienced scientists, Manasa Life Sciences ensures high purity, accurate characterization, and consistent quality across its nitrosamine impurity products.
Recognized as a trusted nitrosamine impurity manufacturer and supplier, Manasa Life Sciences serves pharmaceutical manufacturers, CROs, and research laboratories worldwide. The company’s SEO-focused strength lies in its ability to deliver reliable nitrosamine impurity reference standards with fast turnaround times and technical support. Through continuous innovation, regulatory compliance, and customer-focused solutions, Manasa Life Sciences remains a preferred partner for nitrosamine impurity solutions globally.
By providing access to high-quality nitrosamine impurities, Manasa Life Sciences empowers researchers to effectively develop, validate, and test analytical methods for detecting nitrosamine presence in pharmaceuticals, food products, and other matrices. Our scientifically designed impurity standards support accurate nitrosamine risk assessment and help implement Strong to minimize nitrosamine formation during manufacturing processes, ensuring the safety, quality, and efficacy of drug products.
Our product range includes widely regulated nitrosamines such as N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosodi-n-propylamine (NDPA), and N-Nitrosodibutylamine (NDBA), along with many other nitrosamine impurity standards. Each product is supplied with complete documentation, including COA and structural confirmation, to support regulatory and analytical requirements. We supply to Asia, Europe, Africa, GCC, and UAE markets, ensuring reliable delivery, traceability, and Good Documentation Practices for Active Pharmaceutical Ingredients (APIs) and dosage forms.
